Avasimibe is an orally bioavailable inhibitor of the acyl coenzyme A: cholesterol acyltransferase (ACAT) (IC₅₀ = 60 nM). Avasimibe a lso inhibits major drug metabolizing enzymes such as CYP2C9 (IC₅₀ = 2.9 µM ), CYP1A2 (IC₅₀ = 13.9 µM), and CYP2C19 (I

Item Number: BIOV9506-5
Unit of Measure: 5 MG
https://grogg-prod.braintec.cloud/web/image/product.template/929041/image_1920?unique=b52b68c

108.00 CHF 108.0 CHF 108.00 CHF

108.00 CHF

Not Available For Sale

    This combination does not exist.

    Current delivery time on request

    Manufacturer: BIOVISION
    Manufacturer Number: 9506-5
    Storage Temperature: Freezer (-20)

    Avasimibe is an orally bioavailable inhibitor of the acyl coenzyme A: cholesterol acyltransferase (ACAT) (IC₅₀ = 60 nM). Avasimibe a lso inhibits major drug metabolizing enzymes such as CYP2C9 (IC₅₀ = 2.9 µM ), CYP1A2 (IC₅₀ = 13.9 µM), and CYP2C19 (I